{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:49:49Z","timestamp":1790743789210,"version":"4.1.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T00:00:00Z","timestamp":1513036800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"German Federal Ministry of Education and Research","award":["03X0020"],"award-info":[{"award-number":["03X0020"]}]},{"name":"German Federal Ministry of Education and Research","award":["0315280F"],"award-info":[{"award-number":["0315280F"]}]},{"name":"German Federal Ministry of Education and Research","award":["0316186C"],"award-info":[{"award-number":["0316186C"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharmacokinet Pharmacodyn"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s10928-017-9559-4","type":"journal-article","created":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T02:17:23Z","timestamp":1513045043000},"page":"235-257","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":114,"title":["A generic whole body physiologically based pharmacokinetic model for therapeutic proteins in PK-Sim"],"prefix":"10.1007","volume":"45","author":[{"given":"Christoph","family":"Niederalt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Kuepfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juri","family":"Solodenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Eissing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Ulrich","family":"Siegmund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Willmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Lippert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,12]]},"reference":[{"issue":"9","key":"9559_CR1","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1517\/17425255.4.9.1143","volume":"4","author":"AN Edginton","year":"2008","unstructured":"Edginton AN, Theil FP, Schmitt W, Willmann S (2008) Whole body physiologically-based pharmacokinetic models: their use in clinical drug development. Expert Opin Drug Metab Toxicol 4(9):1143\u20131152. https:\/\/doi.org\/10.1517\/17425255.4.9.1143","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"3","key":"9559_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/cpt.37","volume":"97","author":"HM Jones","year":"2015","unstructured":"Jones HM, Chen Y, Gibson C, Heimbach T, Parrott N, Peters SA, Snoeys J, Upreti VV, Zheng M, Hall SD (2015) Physiologically based pharmacokinetic modeling in drug discovery and development: a pharmaceutical industry perspective. Clin Pharmacol Ther 97(3):247\u2013262. https:\/\/doi.org\/10.1002\/cpt.37","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"9559_CR3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/psp4.12134","volume":"5","author":"L Kuepfer","year":"2016","unstructured":"Kuepfer L, Niederalt C, Wendl T, Schlender JF, Willmann S, Lippert J, Snoeys J, Block M, Eissing T, Teutonico D (2016) Applied concepts in PBPK modeling: how to build a PBPK\/PD model. CPT Pharmacomet Syst Pharmacol 5(10):516\u2013531. https:\/\/doi.org\/10.1002\/psp4.12134","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"issue":"10","key":"9559_CR4","doi-asserted-by":"publisher","first-page":"883","DOI":"10.2165\/00003088-200342100-00002","volume":"42","author":"I Nestorov","year":"2003","unstructured":"Nestorov I (2003) Whole body pharmacokinetic models. Clin Pharmacokinet 42(10):883\u2013908. https:\/\/doi.org\/10.2165\/00003088-200342100-00002","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"9559_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1517\/17425255.3.2.235","volume":"3","author":"I Nestorov","year":"2007","unstructured":"Nestorov I (2007) Whole-body physiologically based pharmacokinetic models. Expert Opin Drug Metab Toxicol 3(2):235\u2013249. https:\/\/doi.org\/10.1517\/17425255.3.2.235","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"9559_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev-pharmtox-010510-100540","volume":"51","author":"M Rowland","year":"2011","unstructured":"Rowland M, Peck C, Tucker G (2011) Physiologically-based pharmacokinetics in drug development and regulatory science. Annu Rev Pharmacol Toxicol 51:45\u201373. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010510-100540","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"9559_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1208\/s12248-012-9446-2","volume":"15","author":"HM Jones","year":"2013","unstructured":"Jones HM, Mayawala K, Poulin P (2013) Dose selection based on physiologically based pharmacokinetic (PBPK) approaches. AAPS J 15(2):377\u2013387. https:\/\/doi.org\/10.1208\/s12248-012-9446-2","journal-title":"AAPS J"},{"issue":"1","key":"9559_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/jps.24214","volume":"104","author":"C Thiel","year":"2015","unstructured":"Thiel C, Schneckener S, Krauss M, Ghallab A, Hofmann U, Kanacher T, Zellmer S, Gebhardt R, Hengstler JG, Kuepfer L (2015) A systematic evaluation of the use of physiologically based pharmacokinetic modeling for cross-species extrapolation. J Pharm Sci 104(1):191\u2013206. https:\/\/doi.org\/10.1002\/jps.24214","journal-title":"J Pharm Sci"},{"issue":"9","key":"9559_CR9","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/nbt1142","volume":"23","author":"P Holliger","year":"2005","unstructured":"Holliger P, Hudson PJ (2005) Engineered antibody fragments and the rise of single domains. Nat Biotechnol 23(9):1126\u20131136. https:\/\/doi.org\/10.1038\/nbt1142","journal-title":"Nat Biotechnol"},{"issue":"1","key":"9559_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrd2399","volume":"7","author":"B Leader","year":"2008","unstructured":"Leader B, Baca QJ, Golan DE (2008) Protein therapeutics: a summary and pharmacological classification. Nat Rev Drug Discov 7(1):21\u201339. https:\/\/doi.org\/10.1038\/nrd2399","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"9559_CR11","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/clpt.2008.170","volume":"84","author":"W Wang","year":"2008","unstructured":"Wang W, Wang EQ, Balthasar JP (2008) Monoclonal antibody pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther 84(5):548\u2013558. https:\/\/doi.org\/10.1038\/clpt.2008.170","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"9559_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/19420862.2016.1269580","volume":"9","author":"JM Reichert","year":"2017","unstructured":"Reichert JM (2017) Antibodies to watch in 2017. mAbs 9(2):167\u2013181. https:\/\/doi.org\/10.1080\/19420862.2016.1269580","journal-title":"mAbs"},{"issue":"23\u201324","key":"9559_CR13","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.drudis.2007.10.002","volume":"12","author":"BM Agoram","year":"2007","unstructured":"Agoram BM, Martin SW, van der Graaf PH (2007) The role of mechanism-based pharmacokinetic\u2013pharmacodynamic (PK\u2013PD) modelling in translational research of biologics. Drug Discov Today 12(23\u201324):1018\u20131024. https:\/\/doi.org\/10.1016\/j.drudis.2007.10.002","journal-title":"Drug Discov Today"},{"issue":"1","key":"9559_CR14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/138920006774832604","volume":"7","author":"A Baumann","year":"2006","unstructured":"Baumann A (2006) Early development of therapeutic biologics\u2014pharmacokinetics. Curr Drug Metab 7(1):15\u201321","journal-title":"Curr Drug Metab"},{"issue":"11","key":"9559_CR15","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/jps.20178","volume":"93","author":"E Lobo","year":"2004","unstructured":"Lobo E, Hansen R, Balthasar J (2004) Antibody pharmacokinetics and pharmacodynamics. J Pharm Sci 93(11):2645","journal-title":"J Pharm Sci"},{"issue":"3","key":"9559_CR16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/138920021503140412212905","volume":"15","author":"S Shi","year":"2014","unstructured":"Shi S (2014) Biologics: an update and challenge of their pharmacokinetics. Curr Drug Metab 15(3):271\u2013290","journal-title":"Curr Drug Metab"},{"issue":"20","key":"9559_CR17","first-page":"4611","volume":"55","author":"L Baxter","year":"1995","unstructured":"Baxter L, Zhu H, Mackensen D, Butler W, Jain R (1995) Biodistribution of monoclonal antibodies: scale-up from mouse to human using a physiologically based pharmacokinetic model. Cancer Res 55(20):4611\u20134622","journal-title":"Cancer Res"},{"issue":"6","key":"9559_CR18","first-page":"1517","volume":"54","author":"L Baxter","year":"1994","unstructured":"Baxter L, Zhu H, Mackensen D, Jain R (1994) Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice. Cancer Res 54(6):1517\u20131528","journal-title":"Cancer Res"},{"key":"9559_CR19","doi-asserted-by":"publisher","first-page":"4318","DOI":"10.1109\/IEMBS.2011.6091072","volume":"2011","author":"JR Chabot","year":"2011","unstructured":"Chabot JR, Dettling DE, Jasper PJ, Gomes BC (2011) Comprehensive mechanism-based antibody pharmacokinetic modeling. Conf Proc Annu Int Conf IEEE Eng Med Biol Soc 2011:4318\u20134323. https:\/\/doi.org\/10.1109\/IEMBS.2011.6091072","journal-title":"Conf Proc Annu Int Conf IEEE Eng Med Biol Soc"},{"issue":"4","key":"9559_CR20","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1208\/s12248-012-9395-9","volume":"14","author":"Y Chen","year":"2012","unstructured":"Chen Y, Balthasar JP (2012) Evaluation of a catenary PBPK model for predicting the in vivo disposition of mAbs engineered for high-affinity binding to FcRn. AAPS J 14(4):850\u2013859. https:\/\/doi.org\/10.1208\/s12248-012-9395-9","journal-title":"AAPS J"},{"key":"9559_CR21","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3389\/fimmu.2014.00670","volume":"5","author":"M Chetty","year":"2014","unstructured":"Chetty M, Li L, Rose R, Machavaram K, Jamei M, Rostami-Hodjegan A, Gardner I (2014) Prediction of the pharmacokinetics, pharmacodynamics, and efficacy of a monoclonal antibody, using a physiologically based pharmacokinetic FcRn model. Front Immunol 5:670. https:\/\/doi.org\/10.3389\/fimmu.2014.00670","journal-title":"Front Immunol"},{"issue":"8","key":"9559_CR22","first-page":"3969","volume":"46","author":"DG Covell","year":"1986","unstructured":"Covell DG, Barbet J, Holton OD, Black CD, Parker RJ, Weinstein JN (1986) Pharmacokinetics of monoclonal immunoglobulin G1, F(ab\u2032)2, and Fab\u2032 in mice. Cancer Res 46(8):3969\u20133978","journal-title":"Cancer Res"},{"issue":"3","key":"9559_CR23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.intimp.2007.10.023","volume":"8","author":"J Davda","year":"2008","unstructured":"Davda J, Jain M, Batra S, Gwilt P, Robinson D (2008) A physiologically based pharmacokinetic (PBPK) model to characterize and predict the disposition of monoclonal antibody CC49 and its single chain Fv constructs. Int Immunopharmacol 8(3):401\u2013413","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"9559_CR24","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1158\/1535-7163.MCT-06-0072","volume":"5","author":"G Ferl","year":"2006","unstructured":"Ferl G, Kenanova V, Wu A, DiStefano J III (2006) A two-tiered physiologically based model for dually labeled single-chain Fv\u2013Fc antibody fragments. Mol Cancer Ther 5(6):1550","journal-title":"Mol Cancer Ther"},{"issue":"11","key":"9559_CR25","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1007\/s10439-005-7410-3","volume":"33","author":"G Ferl","year":"2005","unstructured":"Ferl G, Wu A, DiStefano J (2005) A predictive model of therapeutic monoclonal antibody dynamics and regulation by the neonatal Fc receptor (FcRn). Ann Biomed Eng 33(11):1640\u20131652","journal-title":"Ann Biomed Eng"},{"issue":"2","key":"9559_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10928-014-9349-1","volume":"41","author":"L Fronton","year":"2014","unstructured":"Fronton L, Pilari S, Huisinga W (2014) Monoclonal antibody disposition: a simplified PBPK model and its implications for the derivation and interpretation of classical compartment models. J Pharmacokinet Pharmacodyn 41(2):87\u2013107. https:\/\/doi.org\/10.1007\/s10928-014-9349-1","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"5","key":"9559_CR27","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s10928-007-9065-1","volume":"34","author":"A Garg","year":"2007","unstructured":"Garg A, Balthasar J (2007) Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice. J Pharmacokinet Pharmacodyn 34(5):687\u2013709","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"1","key":"9559_CR28","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1208\/s12248-015-9819-4","volume":"18","author":"KL Gill","year":"2016","unstructured":"Gill KL, Gardner I, Li L, Jamei M (2016) A bottom-up whole-body physiologically based pharmacokinetic model to mechanistically predict tissue distribution and the rate of subcutaneous absorption of therapeutic proteins. AAPS J 18(1):156\u2013170. https:\/\/doi.org\/10.1208\/s12248-015-9819-4","journal-title":"AAPS J"},{"issue":"2","key":"9559_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10928-014-9402-0","volume":"42","author":"A Sepp","year":"2015","unstructured":"Sepp A, Berges A, Sanderson A, Meno-Tetang G (2015) Development of a physiologically based pharmacokinetic model for a domain antibody in mice using the two-pore theory. J Pharmacokinet Pharmacodyn 42(2):97\u2013109. https:\/\/doi.org\/10.1007\/s10928-014-9402-0","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"1","key":"9559_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10928-011-9232-2","volume":"39","author":"DK Shah","year":"2012","unstructured":"Shah DK, Betts AM (2012) Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human. J Pharmacokinet Pharmacodyn 39(1):67\u201386. https:\/\/doi.org\/10.1007\/s10928-011-9232-2","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"3","key":"9559_CR31","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1002\/jps.21918","volume":"99","author":"SR Urva","year":"2010","unstructured":"Urva SR, Yang VC, Balthasar JP (2010) Physiologically based pharmacokinetic model for T84.66: a monoclonal anti-CEA antibody. J Pharm Sci 99(3):1582\u20131600. https:\/\/doi.org\/10.1002\/jps.21918","journal-title":"J Pharm Sci"},{"key":"9559_CR32","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-016-9911-4","author":"CM Ng","year":"2016","unstructured":"Ng CM, Fielder PJ, Jin J, Deng R (2016) Mechanism-based competitive binding model to investigate the effect of neonatal Fc receptor binding affinity on the pharmacokinetic of humanized anti-VEGF monoclonal IgG antibody in cynomolgus monkey. AAPS J. https:\/\/doi.org\/10.1208\/s12248-016-9911-4","journal-title":"AAPS J"},{"issue":"3","key":"9559_CR33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10928-007-9053-5","volume":"34","author":"S Willmann","year":"2007","unstructured":"Willmann S, Hohn K, Edginton A, Sevestre M, Solodenko J, Weiss W, Lippert J, Schmitt W (2007) Development of a physiology-based whole-body population model for assessing the influence of individual variability on the pharmacokinetics of drugs. J Pharmacokinet Pharmacodyn 34(3):401\u2013431","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"1","key":"9559_CR34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1517\/17425255.1.1.159","volume":"1","author":"S Willmann","year":"2005","unstructured":"Willmann S, Lippert J, Schmitt W (2005) From physicochemistry to absorption and distribution: predictive mechanistic modelling and computational tools. Expert Opin Drug Metab Toxicol 1(1):159\u2013168","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"4","key":"9559_CR35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1478-5382(03)02342-4","volume":"1","author":"S Willmann","year":"2003","unstructured":"Willmann S, Lippert J, Sevestre M, Solodenko J, Fois F, Schmitt W (2003) PK-Sim\u00a9: a physiologically based pharmacokinetic \u2018whole-body\u2019 model. Biosilico 1(4):121\u2013124","journal-title":"Biosilico"},{"issue":"12","key":"9559_CR36","doi-asserted-by":"publisher","first-page":"5324","DOI":"10.1002\/jps.22726","volume":"100","author":"K Thelen","year":"2011","unstructured":"Thelen K, Coboeken K, Willmann S, Burghaus R, Dressman JB, Lippert J (2011) Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part 1: oral solutions. J Pharm Sci 100(12):5324\u20135345. https:\/\/doi.org\/10.1002\/jps.22726","journal-title":"J Pharm Sci"},{"key":"9559_CR37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fphys.2011.00004","volume":"2","author":"T Eissing","year":"2011","unstructured":"Eissing T, Kuepfer L, Becker C, Block M, Coboeken K, Gaub T, Goerlitz L, Jaeger J, Loosen R, Ludewig B, Meyer M, Niederalt C, Sevestre M, Siegmund HU, Solodenko J, Thelen K, Telle U, Weiss W, Wendl T, Willmann S, Lippert J (2011) A computational systems biology software platform for multiscale modeling and simulation: integrating whole-body physiology, disease biology, and molecular reaction networks. Front Physiol 2:4. https:\/\/doi.org\/10.3389\/fphys.2011.00004","journal-title":"Front Physiol"},{"issue":"7","key":"9559_CR38","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1517\/17425250902992901","volume":"5","author":"L Gibiansky","year":"2009","unstructured":"Gibiansky L, Gibiansky E (2009) Target-mediated drug disposition model: approximations, identifiability of model parameters and applications to the population pharmacokinetic\u2013pharmacodynamic modeling of biologics. Expert Opin Drug Metab Toxicol 5(7):803\u2013812. https:\/\/doi.org\/10.1517\/17425250902992901","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"9559_CR39","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1038\/psp.2013.40","volume":"2","author":"S Schaller","year":"2013","unstructured":"Schaller S, Willmann S, Lippert J, Schaupp L, Pieber TR, Schuppert A, Eissing T (2013) A generic integrated physiologically based whole-body model of the glucose\u2013insulin\u2013glucagon regulatory system. CPT Pharmacomet Syst Pharmacol 2:e65. https:\/\/doi.org\/10.1038\/psp.2013.40","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"9559_CR40","doi-asserted-by":"publisher","first-page":"e134","DOI":"10.1038\/psp.2014.31","volume":"3","author":"X Chen","year":"2014","unstructured":"Chen X, Hickling TP, Vicini P (2014) A mechanistic, multiscale mathematical model of immunogenicity for therapeutic proteins: part 2-model applications. CPT Pharmacomet Syst Pharmacol 3:e134. https:\/\/doi.org\/10.1038\/psp.2014.31","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"9559_CR41","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1038\/psp.2014.30","volume":"3","author":"X Chen","year":"2014","unstructured":"Chen X, Hickling TP, Vicini P (2014) A mechanistic, multiscale mathematical model of immunogenicity for therapeutic proteins: part 1\u2014theoretical model. CPT Pharmacomet Syst Pharmacol 3:e133. https:\/\/doi.org\/10.1038\/psp.2014.30","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"issue":"7","key":"9559_CR42","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","volume":"10","author":"B Davies","year":"1993","unstructured":"Davies B, Morris T (1993) Physiological parameters in laboratory animals and humans. Pharm Res 10(7):1093\u20131095","journal-title":"Pharm Res"},{"issue":"10","key":"9559_CR43","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.2165\/00003088-200645100-00005","volume":"45","author":"AN Edginton","year":"2006","unstructured":"Edginton AN, Schmitt W, Willmann S (2006) Development and evaluation of a generic physiologically based pharmacokinetic model for children. Clin Pharmacokinet 45(10):1013\u20131034. https:\/\/doi.org\/10.2165\/00003088-200645100-00005","journal-title":"Clin Pharmacokinet"},{"issue":"11","key":"9559_CR44","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/jps.2600751104","volume":"75","author":"J Mordenti","year":"1986","unstructured":"Mordenti J (1986) Man versus beast: pharmacokinetic scaling in mammals. J Pharm Sci 75(11):1028\u20131040","journal-title":"J Pharm Sci"},{"issue":"3","key":"9559_CR45","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1748-1716.1987.tb08257.x","volume":"131","author":"B Rippe","year":"1987","unstructured":"Rippe B, Haraldsson B (1987) Fluid and protein fluxes across small and large pores in the microvasculature. Application of two-pore equations. Acta Physiol Scand 131(3):411\u2013428","journal-title":"Acta Physiol Scand"},{"issue":"1","key":"9559_CR46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1152\/physrev.1994.74.1.163","volume":"74","author":"B Rippe","year":"1994","unstructured":"Rippe B, Haraldsson B (1994) Transport of macromolecules across microvascular walls: the two-pore theory. Physiol Rev 74(1):163\u2013219","journal-title":"Physiol Rev"},{"key":"9559_CR47","doi-asserted-by":"crossref","DOI":"10.1007\/b137547","volume-title":"Physiologie des Menschen","author":"RF Schmidt","year":"2005","unstructured":"Schmidt RF, Lang F, Thews G (2005) Physiologie des Menschen. Springer, Heidelberg"},{"key":"9559_CR48","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0376-7388(00)82170-5","volume":"6","author":"E Mason","year":"1980","unstructured":"Mason E, Wendt R, Bresler E (1980) Similarity relations (dimensional analysis) for membrane transport. J Membr Sci 6:283\u2013298","journal-title":"J Membr Sci"},{"issue":"2","key":"9559_CR49","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1161\/01.RES.0000255690.03436.ae","volume":"100","author":"WC Aird","year":"2007","unstructured":"Aird WC (2007) Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res 100(2):174\u2013190. https:\/\/doi.org\/10.1161\/01.RES.0000255690.03436.ae","journal-title":"Circ Res"},{"issue":"2","key":"9559_CR50","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1161\/01.RES.0000255691.76142.4a","volume":"100","author":"WC Aird","year":"2007","unstructured":"Aird WC (2007) Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 100(2):158\u2013173. https:\/\/doi.org\/10.1161\/01.RES.0000255691.76142.4a","journal-title":"Circ Res"},{"key":"9559_CR51","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/2040-2384-2-14","volume":"2","author":"H Sarin","year":"2010","unstructured":"Sarin H (2010) Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability. J Angiogenesis Res 2:14. https:\/\/doi.org\/10.1186\/2040-2384-2-14","journal-title":"J Angiogenesis Res"},{"issue":"2","key":"9559_CR52","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.tiv.2007.09.010","volume":"22","author":"W Schmitt","year":"2008","unstructured":"Schmitt W (2008) General approach for the calculation of tissue to plasma partition coefficients. Toxicol In Vitro Int J Publ Assoc BIBRA 22(2):457\u2013467. https:\/\/doi.org\/10.1016\/j.tiv.2007.09.010","journal-title":"Toxicol In Vitro Int J Publ Assoc BIBRA"},{"issue":"Pt 1","key":"9559_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nri2155","volume":"176","author":"AR Pries","year":"2006","unstructured":"Pries AR, Kuebler WM (2006) Normal endothelium. Handb Exp Pharmacol 176(Pt 1):1\u201340. https:\/\/doi.org\/10.1038\/nri2155","journal-title":"Handb Exp Pharmacol"},{"issue":"9","key":"9559_CR54","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/nri2155","volume":"7","author":"DC Roopenian","year":"2007","unstructured":"Roopenian DC, Akilesh S (2007) FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol 7(9):715\u2013725. https:\/\/doi.org\/10.1038\/nri2155","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"9559_CR55","first-page":"995","volume":"24","author":"M Rafajova","year":"2004","unstructured":"Rafajova M, Zatovicova M, Kettmann R, Pastorek J, Pastorekova S (2004) Induction by hypoxia combined with low glucose or low bicarbonate and high posttranslational stability upon reoxygenation contribute to carbonic anhydrase IX expression in cancer cells. Int J Oncol 24(4):995\u20131004","journal-title":"Int J Oncol"},{"issue":"6","key":"9559_CR56","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/ijc.11142","volume":"105","author":"A Chrastina","year":"2003","unstructured":"Chrastina A, Zavada J, Parkkila S, Kaluz S, Kaluzova M, Rajcani J, Pastorek J, Pastorekova S (2003) Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma. Int J Cancer 105(6):873\u2013881. https:\/\/doi.org\/10.1002\/ijc.11142","journal-title":"Int J Cancer"},{"issue":"2","key":"9559_CR57","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1158\/1535-7163.MCT-11-0523","volume":"11","author":"HM Petrul","year":"2012","unstructured":"Petrul HM, Schatz CA, Kopitz CC, Adnane L, McCabe TJ, Trail P, Ha S, Chang YS, Voznesensky A, Ranges G, Tamburini PP (2012) Therapeutic mechanism and efficacy of the antibody\u2013drug conjugate BAY 79-4620 targeting human carbonic anhydrase 9. Mol Cancer Ther 11(2):340\u2013349. https:\/\/doi.org\/10.1158\/1535-7163.MCT-11-0523","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"9559_CR58","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1208\/s12248-009-9129-9","volume":"11","author":"A Garg","year":"2009","unstructured":"Garg A, Balthasar JP (2009) Investigation of the influence of FcRn on the distribution of IgG to the brain. AAPS J 11(3):553\u2013557. https:\/\/doi.org\/10.1208\/s12248-009-9129-9","journal-title":"AAPS J"},{"issue":"33","key":"9559_CR59","doi-asserted-by":"publisher","first-page":"23514","DOI":"10.1074\/jbc.M604292200","volume":"281","author":"WF Dall\u2019Acqua","year":"2006","unstructured":"Dall\u2019Acqua WF, Kiener PA, Wu H (2006) Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn). J Biol Chem 281(33):23514\u201323524. https:\/\/doi.org\/10.1074\/jbc.M604292200","journal-title":"J Biol Chem"},{"issue":"27\u201328","key":"9559_CR60","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1016\/j.vaccine.2008.04.042","volume":"26","author":"CP Taylor","year":"2008","unstructured":"Taylor CP, Tummala S, Molrine D, Davidson L, Farrell RJ, Lembo A, Hibberd PL, Lowy I, Kelly CP (2008) Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A. Vaccine 26(27\u201328):3404\u20133409. https:\/\/doi.org\/10.1016\/j.vaccine.2008.04.042","journal-title":"Vaccine"},{"issue":"11","key":"9559_CR61","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/jps.2600721103","volume":"72","author":"A Tsuji","year":"1983","unstructured":"Tsuji A, Yoshikawa T, Nishide K, Minami H, Kimura M, Nakashima E, Terasaki T, Miyamoto E, Nightingale CH, Yamana T (1983) Physiologically based pharmacokinetic model for beta-lactam antibiotics I: tissue distribution and elimination in rats. J Pharm Sci 72(11):1239\u20131252","journal-title":"J Pharm Sci"},{"issue":"3","key":"9559_CR62","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1128\/AAC.49.3.959-962.2005","volume":"49","author":"S Reilley","year":"2005","unstructured":"Reilley S, Wenzel E, Reynolds L, Bennett B, Patti JM, Hetherington S (2005) Open-label, dose escalation study of the safety and pharmacokinetic profile of tefibazumab in healthy volunteers. Antimicrob Agents Chemother 49(3):959\u2013962. https:\/\/doi.org\/10.1128\/AAC.49.3.959-962.2005","journal-title":"Antimicrob Agents Chemother"},{"key":"9559_CR63","volume-title":"Blood and other body fluids","author":"PL Altman","year":"1961","unstructured":"Altman PL (1961) Blood and other body fluids. Federation of American Societies for Experimental Biology, Washington, DC"},{"issue":"12","key":"9559_CR64","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3109\/00498254.2014.941963","volume":"44","author":"K Haraya","year":"2014","unstructured":"Haraya K, Tachibana T, Nanami M, Ishigai M (2014) Application of human FcRn transgenic mice as a pharmacokinetic screening tool of monoclonal antibody. Xenobiotica Fate Foreign Compd Biol Syst 44(12):1127\u20131134. https:\/\/doi.org\/10.3109\/00498254.2014.941963","journal-title":"Xenobiotica Fate Foreign Compd Biol Syst"},{"issue":"4","key":"9559_CR65","doi-asserted-by":"publisher","first-page":"F605","DOI":"10.1152\/ajprenal.00171.2004","volume":"288","author":"D Venturoli","year":"2005","unstructured":"Venturoli D, Rippe B (2005) Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformability. Am J Physiol Renal Physiol 288(4):F605\u2013F613. https:\/\/doi.org\/10.1152\/ajprenal.00171.2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"9559_CR66","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev.pharmtox.48.113006.094708","volume":"48","author":"BJ Anderson","year":"2008","unstructured":"Anderson BJ, Holford NH (2008) Mechanism-based concepts of size and maturity in pharmacokinetics. Annu Rev Pharmacol Toxicol 48:303\u2013332. https:\/\/doi.org\/10.1146\/annurev.pharmtox.48.113006.094708","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"6","key":"9559_CR67","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1113\/expphysiol.1991.sp003549","volume":"76","author":"JR Levick","year":"1991","unstructured":"Levick JR (1991) Capillary filtration\u2013absorption balance reconsidered in light of dynamic extravascular factors. Exp Physiol 76(6):825\u2013857","journal-title":"Exp Physiol"},{"issue":"5","key":"9559_CR68","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1021\/mp300214k","volume":"10","author":"L Abuqayyas","year":"2013","unstructured":"Abuqayyas L, Balthasar JP (2013) Investigation of the role of FcgammaR and FcRn in mAb distribution to the brain. Mol Pharm 10(5):1505\u20131513. https:\/\/doi.org\/10.1021\/mp300214k","journal-title":"Mol Pharm"},{"issue":"5","key":"9559_CR69","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1021\/mp300518e","volume":"10","author":"N Strazielle","year":"2013","unstructured":"Strazielle N, Ghersi-Egea JF (2013) Physiology of blood\u2013brain interfaces in relation to brain disposition of small compounds and macromolecules. Mol Pharm 10(5):1473\u20131491. https:\/\/doi.org\/10.1021\/mp300518e","journal-title":"Mol Pharm"},{"issue":"3","key":"9559_CR70","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ki.1979.128","volume":"16","author":"T Maack","year":"1979","unstructured":"Maack T, Johnson V, Kau ST, Figueiredo J, Sigulem D (1979) Renal filtration, transport, and metabolism of low-molecular-weight proteins: a review. Kidney Int 16(3):251\u2013270","journal-title":"Kidney Int"},{"issue":"2","key":"9559_CR71","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/jappl.1985.58.2.315","volume":"58","author":"E Renkin","year":"1985","unstructured":"Renkin E (1985) Capillary transport of macromolecules: pores and other endothelial pathways. J Appl Physiol 58(2):315\u2013325","journal-title":"J Appl Physiol"},{"issue":"1","key":"9559_CR72","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1152\/japplphysiol.00635.2000","volume":"93","author":"JR Sanders","year":"2002","unstructured":"Sanders JR, Pou NA, Roselli RJ (2002) Neutral and DEAE dextrans as tracers for assessing lung microvascular barrier permeability and integrity. J Appl Physiol 93(1):251\u2013262. https:\/\/doi.org\/10.1152\/japplphysiol.00635.2000","journal-title":"J Appl Physiol"},{"issue":"4","key":"9559_CR73","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1124\/dmd.109.031310","volume":"38","author":"R Deng","year":"2010","unstructured":"Deng R, Loyet KM, Lien S, Iyer S, DeForge LE, Theil FP, Lowman HB, Fielder PJ, Prabhu S (2010) Pharmacokinetics of humanized monoclonal anti-tumor necrosis factor-{alpha} antibody and its neonatal Fc receptor variants in mice and cynomolgus monkeys. Drug Metab Dispos Biol Chem 38(4):600\u2013605. https:\/\/doi.org\/10.1124\/dmd.109.031310","journal-title":"Drug Metab Dispos Biol Chem"},{"issue":"12","key":"9559_CR74","doi-asserted-by":"publisher","first-page":"7663","DOI":"10.4049\/jimmunol.0804182","volume":"182","author":"YA Yeung","year":"2009","unstructured":"Yeung YA, Leabman MK, Marvin JS, Qiu J, Adams CW, Lien S, Starovasnik MA, Lowman HB (2009) Engineering human IgG1 affinity to human neonatal Fc receptor: impact of affinity improvement on pharmacokinetics in primates. J Immunol 182(12):7663\u20137671. https:\/\/doi.org\/10.4049\/jimmunol.0804182","journal-title":"J Immunol"},{"issue":"4","key":"9559_CR75","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.molimm.2013.05.008","volume":"56","author":"B Gurbaxani","year":"2013","unstructured":"Gurbaxani B, Dostalek M, Gardner I (2013) Are endosomal trafficking parameters better targets for improving mAb pharmacokinetics than FcRn binding affinity? Mol Immunol 56(4):660\u2013674. https:\/\/doi.org\/10.1016\/j.molimm.2013.05.008","journal-title":"Mol Immunol"},{"issue":"4","key":"9559_CR76","doi-asserted-by":"publisher","first-page":"928","DOI":"10.4161\/mabs.28744","volume":"6","author":"T Neuber","year":"2014","unstructured":"Neuber T, Frese K, Jaehrling J, Jager S, Daubert D, Felderer K, Linnemann M, Hohne A, Kaden S, Kolln J, Tiller T, Brocks B, Ostendorp R, Pabst S (2014) Characterization and screening of IgG binding to the neonatal Fc receptor. mAbs 6(4):928\u2013942. https:\/\/doi.org\/10.4161\/mabs.28744","journal-title":"mAbs"},{"issue":"31","key":"9559_CR77","doi-asserted-by":"publisher","first-page":"9374","DOI":"10.1021\/bi970841r","volume":"36","author":"DE Vaughn","year":"1997","unstructured":"Vaughn DE, Bjorkman PJ (1997) High-affinity binding of the neonatal Fc receptor to its IgG ligand requires receptor immobilization. Biochemistry 36(31):9374\u20139380. https:\/\/doi.org\/10.1021\/bi970841r","journal-title":"Biochemistry"},{"issue":"1","key":"9559_CR78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0003-9861(82)90272-7","volume":"215","author":"LA Henderson","year":"1982","unstructured":"Henderson LA, Baynes JW, Thorpe SR (1982) Identification of the sites of IgG catabolism in the rat. Arch Biochem Biophys 215(1):1\u201311","journal-title":"Arch Biochem Biophys"},{"issue":"12","key":"9559_CR79","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/glycob\/10.12.1347","volume":"10","author":"A Wright","year":"2000","unstructured":"Wright A, Sato Y, Okada T, Chang K, Endo T, Morrison S (2000) In vivo trafficking and catabolism of IgG1 antibodies with Fc associated carbohydrates of differing structure. Glycobiology 10(12):1347\u20131355","journal-title":"Glycobiology"},{"issue":"3","key":"9559_CR80","doi-asserted-by":"publisher","first-page":"689","DOI":"10.4161\/mabs.28254","volume":"6","author":"V Yip","year":"2014","unstructured":"Yip V, Palma E, Tesar DB, Mundo EE, Bumbaca D, Torres EK, Reyes NA, Shen BQ, Fielder PJ, Prabhu S, Khawli LA, Boswell CA (2014) Quantitative cumulative biodistribution of antibodies in mice: effect of modulating binding affinity to the neonatal Fc receptor. mAbs 6(3):689\u2013696. https:\/\/doi.org\/10.4161\/mabs.28254","journal-title":"mAbs"},{"issue":"4","key":"9559_CR81","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0008-6363(96)00064-8","volume":"32","author":"CC Michel","year":"1996","unstructured":"Michel CC (1996) Transport of macromolecules through microvascular walls. Cardiovasc Res 32(4):644\u2013653","journal-title":"Cardiovasc Res"},{"issue":"3","key":"9559_CR82","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1152\/physrev.1999.79.3.703","volume":"79","author":"CC Michel","year":"1999","unstructured":"Michel CC, Curry FE (1999) Microvascular permeability. Physiol Rev 79(3):703\u2013761","journal-title":"Physiol Rev"},{"issue":"5","key":"9559_CR83","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000064521","volume":"39","author":"B Rippe","year":"2002","unstructured":"Rippe B, Rosengren BI, Carlsson O, Venturoli D (2002) Transendothelial transport: the vesicle controversy. J Vasc Res 39(5):375\u2013390","journal-title":"J Vasc Res"},{"issue":"2","key":"9559_CR84","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00281-009-0160-9","volume":"31","author":"K Baker","year":"2009","unstructured":"Baker K, Qiao SW, Kuo T, Kobayashi K, Yoshida M, Lencer WI, Blumberg RS (2009) Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn. Semin Immunopathol 31(2):223\u2013236. https:\/\/doi.org\/10.1007\/s00281-009-0160-9","journal-title":"Semin Immunopathol"},{"issue":"6","key":"9559_CR85","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.copbio.2011.06.012","volume":"22","author":"RE Kontermann","year":"2011","unstructured":"Kontermann RE (2011) Strategies for extended serum half-life of protein therapeutics. Curr Opin Biotechnol 22(6):868\u2013876. https:\/\/doi.org\/10.1016\/j.copbio.2011.06.012","journal-title":"Curr Opin Biotechnol"},{"issue":"2","key":"9559_CR86","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10928-015-9406-4","volume":"42","author":"E Offman","year":"2015","unstructured":"Offman E, Edginton AN (2015) A PBPK workflow for first-in-human dose selection of a subcutaneously administered pegylated peptide. J Pharmacokinet Pharmacodyn 42(2):135\u2013150. https:\/\/doi.org\/10.1007\/s10928-015-9406-4","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"11","key":"9559_CR87","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.1007\/s11095-015-1626-1","volume":"32","author":"AP Singh","year":"2015","unstructured":"Singh AP, Shin YG, Shah DK (2015) Application of pharmacokinetic\u2013pharmacodynamic modeling and simulation for antibody\u2013drug conjugate development. Pharm Res 32(11):3508\u20133525. https:\/\/doi.org\/10.1007\/s11095-015-1626-1","journal-title":"Pharm Res"},{"issue":"6","key":"9559_CR88","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1161\/01.RES.41.6.735","volume":"41","author":"EM Renkin","year":"1977","unstructured":"Renkin EM (1977) Multiple pathways of capillary permeability. Circ Res 41(6):735\u2013743","journal-title":"Circ Res"},{"issue":"6","key":"9559_CR89","first-page":"1667","volume":"42","author":"DN Granger","year":"1983","unstructured":"Granger DN, Perry MA, Kvietys PR (1983) The microcirculation and fluid transport in digestive organs. Fed Proc 42(6):1667\u20131672","journal-title":"Fed Proc"},{"issue":"1","key":"9559_CR90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.RES.33.1.1","volume":"33","author":"WM Deen","year":"1973","unstructured":"Deen WM, Robertson CR, Brenner BM (1973) Transcapillary fluid exchange in the renal cortex. Circ Res 33(1):1\u20138","journal-title":"Circ Res"},{"issue":"3 Pt 2","key":"9559_CR91","first-page":"H458","volume":"255","author":"EM Renkin","year":"1988","unstructured":"Renkin EM, Gustafson-Sgro M, Sibley L (1988) Coupling of albumin flux to volume flow in skin and muscles of anesthetized rats. Am J Physiol 255(3 Pt 2):H458\u2013H466","journal-title":"Am J Physiol"},{"issue":"Pt 2","key":"9559_CR92","first-page":"467","volume":"4","author":"AE Taylor","year":"1984","unstructured":"Taylor AE, Granger DN (1984) Exchange of macromolecules across the microcirculation. Handb Physiol Cardiovasc Syst Microcirc 4(Pt 2):467\u2013520","journal-title":"Handb Physiol Cardiovasc Syst Microcirc"},{"issue":"6","key":"9559_CR93","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0896-8411(89)90013-9","volume":"2","author":"AS Klein-Schneegans","year":"1989","unstructured":"Klein-Schneegans AS, Kuntz L, Fonteneau P, Loor F (1989) Serum concentrations of IgM, IgG1, IgG2b, IgG3 and IgA in C57BL\/6 mice and their congenics at the lpr (lymphoproliferation) locus. J Autoimmun 2(6):869\u2013875","journal-title":"J Autoimmun"},{"issue":"3","key":"9559_CR94","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1074\/jbc.M607161200","volume":"282","author":"A Datta-Mannan","year":"2007","unstructured":"Datta-Mannan A, Witcher DR, Tang Y, Watkins J, Wroblewski VJ (2007) Monoclonal antibody clearance. Impact of modulating the interaction of IgG with the neonatal Fc receptor. J Biol Chem 282(3):1709\u20131717. https:\/\/doi.org\/10.1074\/jbc.M607161200","journal-title":"J Biol Chem"},{"issue":"3","key":"9559_CR95","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1475-097X.1981.tb00896.x","volume":"1","author":"N Rossing","year":"1981","unstructured":"Rossing N, Worm AM (1981) Interstitial fluid: exchange of macromolecules between plasma and skin interstitium. Clin Physiol 1(3):275\u2013284","journal-title":"Clin Physiol"},{"issue":"4","key":"9559_CR96","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0022-2836(03)00952-5","volume":"332","author":"J Zhou","year":"2003","unstructured":"Zhou J, Johnson JE, Ghetie V, Ober RJ, Ward ES (2003) Generation of mutated variants of the human form of the MHC class I-related receptor, FcRn, with increased affinity for mouse immunoglobulin G. J Mol Biol 332(4):901\u2013913","journal-title":"J Mol Biol"},{"issue":"10","key":"9559_CR97","first-page":"2641","volume":"48","author":"RK Jain","year":"1988","unstructured":"Jain RK (1988) Determinants of tumor blood flow: a review. Cancer Res 48(10):2641\u20132658","journal-title":"Cancer Res"},{"issue":"12","key":"9559_CR98","first-page":"3039","volume":"47","author":"RK Jain","year":"1987","unstructured":"Jain RK (1987) Transport of molecules in the tumor interstitium: a review. Cancer Res 47(12):3039\u20133051","journal-title":"Cancer Res"},{"issue":"22","key":"9559_CR99","first-page":"5451","volume":"55","author":"PA Netti","year":"1995","unstructured":"Netti PA, Baxter LT, Boucher Y, Skalak R, Jain RK (1995) Time-dependent behavior of interstitial fluid pressure in solid tumors: implications for drug delivery. Cancer Res 55(22):5451\u20135458","journal-title":"Cancer Res"},{"issue":"2","key":"9559_CR100","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0022-3565(24)36469-9","volume":"280","author":"H Ghandehari","year":"1997","unstructured":"Ghandehari H, Smith PL, Ellens H, Yeh PY, Kopecek J (1997) Size-dependent permeability of hydrophilic probes across rabbit colonic epithelium. J Pharmacol Exp Ther 280(2):747\u2013753","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Journal of Pharmacokinetics and Pharmacodynamics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10928-017-9559-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-017-9559-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10928-017-9559-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T10:14:42Z","timestamp":1751105682000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10928-017-9559-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,12]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["9559"],"URL":"https:\/\/doi.org\/10.1007\/s10928-017-9559-4","relation":{},"ISSN":["1567-567X","1573-8744"],"issn-type":[{"value":"1567-567X","type":"print"},{"value":"1573-8744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,12]]}}}